Dermatologic Diagnostics Co. Castle Biosciences Presents New Data

Aitechpark26 Jul, 2021Technology

Data Presented at American Head & Neck Society (AHNS) 10th International Conference on Head and Neck Cancer Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today announced a podium presentation on its DecisionDx?-SCC test at the American Head & Neck Society (AHNS) 10th International Conference on Head and Neck Cancer, being held July 22-25, 2021.